MX9702431A - Metodos para producir bacterias entericas antigenicas mejoradas y vacunas que comprenden las mismas. - Google Patents
Metodos para producir bacterias entericas antigenicas mejoradas y vacunas que comprenden las mismas.Info
- Publication number
- MX9702431A MX9702431A MX9702431A MX9702431A MX9702431A MX 9702431 A MX9702431 A MX 9702431A MX 9702431 A MX9702431 A MX 9702431A MX 9702431 A MX9702431 A MX 9702431A MX 9702431 A MX9702431 A MX 9702431A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- enteric
- enteric bacteria
- bacteria
- same
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/105—Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/025—Enterobacteriales, e.g. Enterobacter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/107—Vibrio
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/045—Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31840994A | 1994-10-05 | 1994-10-05 | |
| US08/538,543 US5681736A (en) | 1994-10-05 | 1995-10-03 | Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same |
| US08/538,545 US5679564A (en) | 1994-10-05 | 1995-10-03 | Methods for producing enhanced antigenic campylobacter bacteria and vaccines |
| PCT/US1995/013196 WO1996011258A1 (en) | 1994-10-05 | 1995-10-04 | Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX9702431A true MX9702431A (es) | 1998-05-31 |
Family
ID=27405987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX9702431A MX9702431A (es) | 1994-10-05 | 1995-10-04 | Metodos para producir bacterias entericas antigenicas mejoradas y vacunas que comprenden las mismas. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0804542A4 (de) |
| JP (1) | JP3394047B2 (de) |
| CN (1) | CN1168693A (de) |
| AU (1) | AU704283B2 (de) |
| BR (1) | BR9509276A (de) |
| CA (1) | CA2202027A1 (de) |
| CZ (1) | CZ104397A3 (de) |
| FI (1) | FI971403L (de) |
| HU (1) | HUT77876A (de) |
| IL (1) | IL115521A0 (de) |
| MX (1) | MX9702431A (de) |
| NO (1) | NO971519L (de) |
| NZ (1) | NZ295907A (de) |
| PL (1) | PL182700B1 (de) |
| SG (2) | SG73509A1 (de) |
| WO (1) | WO1996011258A1 (de) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2255064T3 (es) * | 1994-10-05 | 2006-06-16 | Emergent Immunosolutions Inc. | Procedimientos de produccion de helicobacter sp antigenico potenciado y vacunas que comprenden el mismo. |
| CN102304527A (zh) * | 2003-05-30 | 2012-01-04 | 英特塞尔股份公司 | 肠球菌抗原 |
| WO2007108903A2 (en) * | 2006-03-17 | 2007-09-27 | Cerebus Biologicals, Inc. | Campylobacter vaccines and methods of use |
| EP2161035B1 (de) * | 2007-05-28 | 2019-08-21 | Daiichi Sankyo Company, Limited | Ganzzellige imfpstoffzusammensetzung mit bordetella parapertussis |
| CN107513553B (zh) * | 2017-09-18 | 2021-05-18 | 江南大学 | 一种筛选具有拮抗空肠弯曲杆菌感染功能的乳酸菌的方法 |
| CN109633151B (zh) * | 2018-12-26 | 2022-03-11 | 西北农林科技大学 | 一种肠炎沙门氏菌检测方法、试纸条及应用 |
| US12403187B2 (en) | 2018-12-31 | 2025-09-02 | Bellevacc As | Bacterial vaccine |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06503231A (ja) * | 1991-09-18 | 1994-04-14 | アムジエン・インコーポレーテツド | 胆汁酸塩を含有するｂ型肝炎ワクチン製剤 |
-
1995
- 1995-10-04 MX MX9702431A patent/MX9702431A/es not_active IP Right Cessation
- 1995-10-04 CZ CZ971043A patent/CZ104397A3/cs unknown
- 1995-10-04 JP JP51271696A patent/JP3394047B2/ja not_active Expired - Fee Related
- 1995-10-04 SG SG1998000815A patent/SG73509A1/en unknown
- 1995-10-04 AU AU39561/95A patent/AU704283B2/en not_active Ceased
- 1995-10-04 WO PCT/US1995/013196 patent/WO1996011258A1/en not_active Ceased
- 1995-10-04 FI FI971403A patent/FI971403L/fi not_active IP Right Cessation
- 1995-10-04 CN CN95196589A patent/CN1168693A/zh active Pending
- 1995-10-04 BR BR9509276A patent/BR9509276A/pt not_active Application Discontinuation
- 1995-10-04 CA CA002202027A patent/CA2202027A1/en not_active Abandoned
- 1995-10-04 NZ NZ295907A patent/NZ295907A/en unknown
- 1995-10-04 EP EP95937449A patent/EP0804542A4/de not_active Withdrawn
- 1995-10-04 SG SG1998000819A patent/SG73510A1/en unknown
- 1995-10-04 PL PL95319580A patent/PL182700B1/pl not_active IP Right Cessation
- 1995-10-04 HU HU9702303A patent/HUT77876A/hu unknown
- 1995-10-05 IL IL11552195A patent/IL115521A0/xx unknown
-
1997
- 1997-04-03 NO NO971519A patent/NO971519L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO971519L (no) | 1997-05-27 |
| HUT77876A (hu) | 1998-09-28 |
| EP0804542A4 (de) | 1998-10-28 |
| PL319580A1 (en) | 1997-08-18 |
| BR9509276A (pt) | 1997-11-18 |
| SG73510A1 (en) | 2000-06-20 |
| EP0804542A1 (de) | 1997-11-05 |
| CN1168693A (zh) | 1997-12-24 |
| JPH10507347A (ja) | 1998-07-21 |
| FI971403A0 (fi) | 1997-04-04 |
| IL115521A0 (en) | 1996-06-18 |
| SG73509A1 (en) | 2000-06-20 |
| PL182700B1 (pl) | 2002-02-28 |
| JP3394047B2 (ja) | 2003-04-07 |
| FI971403A7 (fi) | 1997-06-04 |
| CZ104397A3 (cs) | 1998-06-17 |
| NO971519D0 (no) | 1997-04-03 |
| AU3956195A (en) | 1996-05-02 |
| NZ295907A (en) | 1999-04-29 |
| WO1996011258A1 (en) | 1996-04-18 |
| AU704283B2 (en) | 1999-04-15 |
| CA2202027A1 (en) | 1996-04-18 |
| FI971403L (fi) | 1997-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT88329A (pt) | Bacterias nao virulentas contra infeccoes estreptococicas | |
| NO20003226D0 (no) | FremgangsmÕte ved ekstraksjon og isolering av bakterielle kapsulære polysakkarider for anvendelse som vaksiner eller konjugerte vaksiner | |
| ES500567A0 (es) | Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos. | |
| NZ524888A (en) | Nucleic acids and proteins from streptococcus groups A & B | |
| FI101632B1 (fi) | Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä | |
| AU8100101A (en) | New immunoeffector compounds | |
| DK0784483T3 (da) | Præparat indeholdende et rekombinant virus, der udtrykker et antigen, og et rekombinant virus, der udtrykker et immunstimul | |
| MX9203458A (es) | Segmentos inmunogenicos que contienen glicoproteinas quimericas de las glicoproteinas de virus sincitial respiratorio humano. | |
| NO1997010I1 (no) | Bordetella pertussis P69 antigen | |
| PT70610A (fr) | Procede de preparation de proteoglycanes bacteriens destines a etre incorpores avec un vaccin et vaccin qui les contient | |
| MX9702432A (es) | Metodos para producir helicobacter sp. antigenica mejorada y vacuna que comprenden la misma. | |
| CY1109210T1 (el) | Διαγραφεισες αλληλουχιες στο μ. bovis bcg/m. bovis ΄η μ. tuberculosis, μεθοδος ανιχνευσεως μυκοβακτηριων που χρησιμοποιουν αυτες τις αλληλουχιες και εμβολια | |
| GT197854594A (es) | Vacuna contra haemophilus influenzae | |
| DK1154791T3 (da) | Neisseria-vaccinesammensætninger og fremgangsmåder | |
| ATE107516T1 (de) | Pasteurella-impfstoff. | |
| ZA872712B (en) | A process for the purification,solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine | |
| DK421486A (da) | Polydisperse native pseudomonas-flagella(h)-antigener (fag) og fremgangsmaade til deres udvinding | |
| ES468236A1 (es) | Procedimiento para preparar composiciones farmaceuticas an- timicrobiales. | |
| ES8605576A1 (es) | Un procedimiento para preparar una composicion contra infecciones virales de hepatitis b | |
| AU8007391A (en) | Vaccine composition for treating human chlamydial diseases | |
| DK230890A (da) | Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m. | |
| ES432409A1 (es) | Un procedimiento para la obtencion de vacunas contra enfer-medades producidas por enzimas vivientes. | |
| RU99103391A (ru) | Способ получения гипериммунной сыворотки против рожи свиней | |
| ATE87658T1 (de) | Verfahren zur selektiven biokonversion von isosorbid-dinitrat. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration | ||
| MM | Annulment or lapse due to non-payment of fees |